BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Henlius, Sandoz Expand Global Biosimilars Alliance with Up to 10 New Antibody Assets

Collaboration may cover up to 10 proposed monoclonal antibody (mAb) and/or antibody-drug conjugate (ADC) biosimilar assets, with the majority of programs...

August 17, 2026 | News

AbelZeta Secures US FDA IND Clearance for Bispecific CAR-T Therapy C-CAR039 in Large B-cell Lymphoma

AbelZeta Pharma, Inc. ("AbelZeta" or the "Company"), a global clinical-stage biopharmaceutical company focused on the discovery and development of innovati...

August 17, 2026 | News

6 Radiopharmaceutical Programmes and Sites to Watch in APAC

Radioligand therapy is the one modality a region cannot buy its way into late. A vial of lutetium-177 loses half its therapeutic activity in roughly six an...

August 17, 2026 | Analysis

Optellum, Coreline Soft Join Forces to Build Integrated AI Pathway for Lung Nodule Care

Proposed collaboration would make Coreline Soft's FDA-cleared lung nodule detection capability available through Optellum's LungOS® platform &nbs...

August 17, 2026 | News

SK bioscience Seeks South Africa Approval to Begin Phase 1b Trial of RSV Preventive Antibody RSM01

Phase 1b study will evaluate safety and pharmacokinetics of RSM01 in approximately 80 infants aged 2 weeks to 8 months Company expands its global portfo...

August 17, 2026 | News

IASO Bio Acquires Singapore’s MediSix Therapeutics to Strengthen Global Cell Therapy Platform

- IASO Biotechnology announced the completion of its acquisition of MediSix Therapeutics , a Singapore-based immune cell engineering and cell therapy compa...

August 17, 2026 | News

China Approves Geneseeq’s PanTRKare as Companion Diagnostic for VELMARTO

NMPA granted approval to Geneseeq's PanTRKare™ NTRK1/2/3 Gene Fusion Detection Kit as a companion diagnostic for VELMARTO® (Eratrectini...

August 14, 2026 | News

China Accepts Laekna’s NDA for Afuresertib in Advanced Breast Cancer

Laekna (2105.HK) announced that the New Drug Application (NDA) for LAE002 (afuresertib) has been accepted by the Center for Drug Evaluation (CDE) of China'...

August 13, 2026 | News

Thermo Fisher, Michael J. Fox Foundation Expand Parkinson’s Proteomics Resource with 5,500 Samples

Olink™ Explore HT analysis of approximately 5,500 research samples completed, with data now available Key Facts Collaboration: Thermo Fisher...

August 13, 2026 | News

Aureka Biotechnologies Raises $100M Series B to Advance AI-Driven Drug Discovery

Aureka Biotechnologies announced the close of a US$100 million Series B financing on Aug. 10, 2026. Granite Asia funded the first tranche exclusively, and ...

August 12, 2026 | News

Mabwell Clears Brazil ANVISA GMP Inspection for Denosumab Biosimilars

Mabwell (688062.SH, 02493.HK), an innovation-driven biopharmaceutical company with a fully integrated industry chain, announces that its wholly-owned...

August 11, 2026 | News

Innovent, Daiichi Sankyo Partner to Commercialise Vanflyta for FLT3-ITD Positive AML in China

Collaboration to accelerate access to Vanflyta® for patients with newly diagnosed FLT3-ITD positive AML Innovent Bio...

August 11, 2026 | News

RiboX Secures FDA IND Clearance for World’s First Circular RNA-Based In Vivo CAR-T Therapy

The FDA IND clearance supports the initiation of RiboX's Phase 1 clinical trial evaluating targeted LNP-delivered circular RNA-based in vivo CAR-T therapy ...

August 10, 2026 | News

Ono and Mediar Partner to Develop Novel Antibody Therapies for Fibro-Inflammatory Diseases

Commencing a drug discovery partnership to create novel antibody therapeutics for fibro-inflammatory diseases with high unmet medical need Leveraging ...

August 10, 2026 | News

Stay Connected